Clinical TrialID 5624
Second-line Therapy for Patients With Progressive Poorly Differentiated Extra-pulmonary Neuroendocrine Carcinoma
NCT03837977
Oncology|Neuroendocrine Carcinoma
Relationship Network
Interactive first-hop connections across herbs, ingredients, formulas, targets, diseases, symptoms, syndromes, evidence, and monographs.
Click a node to open it in a new tab
Trial: 1Ingredient: 1Links: 1
Arranging relationship network...
Record Fields
Scalar fields from the final clinical_trial record.
- Clinical Trial Id
- 5624
- Evidence Id
- 5624
- Core Evidence Id
- 5624
- Source Clinical Trial Id
- 5608
- Herb2 Clinical Trial Id
- HBCT005608
- Nct Id
- NCT03837977
- Title
- Second-line Therapy for Patients With Progressive Poorly Differentiated Extra-pulmonary Neuroendocrine Carcinoma
- Status
- Active_Not_Recruiting
- Phase
- Phase 2
- Study Result
- No
- Study Condition
- Oncology|Neuroendocrine Carcinoma
- Study Type
- Interventional
- Study Design
- Allocation: RANDOMIZED|Intervention Model: PARALLEL|Masking: NONE|Primary Purpose: TREATMENT
- Intervention
- DRUG: Liposomal Irinotecan|DRUG: Fluorouracil|DRUG: Folinic Acid|DRUG: Docetaxel
- Intervention Allocation
- Randomized
- Intervention Model
- Parallel
- Intervention Mask
- Intervention Purpose
- Treatment
- Gender
- All
- Age
- Adult, Older_Adult
- Enrollment
- 102
- Outcome Measure
- Progression-free survival defined as a binary outcome (progression-free or not), treatment start date until 6 months, assessed at 8 weekly intervals by CT scan
- Sponsor Collaborator
- The Christie NHS Foundation Trust|University of Leeds|Servier|National Institute for Health Research, United Kingdom
- Funded By
- OTHER
- Location
- The Beaston West of Scotland Cancer Center, NHS Greater Glasgow and Clyde, Glasgow, United Kingdom|Hammersmith Hospital, Imperial College Healthcare NHS Trust, London, United Kingdom|The Christie NHS Foundation Trust, Manchester, M20 4BX, United Kingdom|Weston Park Hospital, Sheffield Teaching Hospitals, NHS Trust, Sheffield, United Kingdom
- Other Id
- CFTSp116
- Start Date
- 2018-11-13
- Primary Completion Date
- 2023-12-01
- Completion Date
- 2023-12-01
- First Posted
- 2019-02-12
- Results First Posted
- Last Update Posted
- 2023-06-09
- Study Document
- Study Url
- https://clinicaltrials.gov/study/NCT03837977
- Title Cn
- Title En
- Second-line Therapy for Patients With Progressive Poorly Differentiated Extra-pulmonary Neuroendocrine Carcinoma
- Bilingual Status
- semi_complete